New order of WorkBeads - the next generation of protein purification - to Spanish CDMO 3P Biopharmaceuticals
Bio-Works confirms a new order of WorkBeads, the company's product line for advanced protein purification, to the Spanish contract and manufacturing organization 3P Biopharmaceuticals. The order has been received via Swedish biotech company Toleranzia and the value amounts to SEK 1.3 million.
"Bio-Works is very pleased to be able to support 3P Biopharmaceutics in their mission to deliver advanced drugs to improve lives," says Jonathan Royce, CEO of Bio-Works Technologies. This order also confirms that our investment in continued establishment in Europe is progressing according to plan.”
3P Biopharmaceuticals is a global contract development and manufacturing organization (CDMO) specializing in the manufacture of biological drugs and cell therapy products. Based in Pamplona, Spain, they provide clinical and commercial manufacturing of biological drugs at their GMP-approved facilities.
Toleranzia AB (publ) develops drugs that harness the power of the immune system for the treatment of autoimmune orphan diseases. The drugs, which target the cause of the disease, can alleviate or cure the disease and not, like current treatments, merely reduce the symptoms. They have the potential to be the first long-acting or curative therapies that act specifically on the underlying cause of the autoimmune orphan disease for which they are being developed. Toleranzia’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, 08 503 015 50, CA@mangold.se, is the Company’s Certified Adviser.
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Jonathan Royce, CEO, e-mail: jonathan.royce@bio-works.com, phone: +46 70 1434143.
About Bio-Works
Bio-Works enables scientists to achieve their purification goals, from laboratory research to large scale bioprocess production. Our vision is a biotech industry that embraces, develops and builds on new methods and novel ideas. WorkBeads™, Bio-Works’ next-generation, agarose-based products, are used to purify proteins, peptides and other biomolecules, resulting in purer therapies and safer diagnostics. Through collaboration with customers and partners, we develop purification solutions that make important medicines available and accessible to everyone.
Bio-Works’ headquarters, with R&D and manufacturing, is located in Uppsala Business Park in Uppsala, Sweden. We supply products globally, through a combination of direct sales and via distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Nasdaq First North (“BIOWKS”), and FNCA Sweden AB, +46 (0) 8-528 00 399, info@fnca.se, is appointed Certified Adviser. For more information, www.bio-works.com.